High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
AstraZeneca (NASDAQ: AZN) and Bristol Myers Squibb (NYSE: BMY) are the two directly affected public companies; AZN bears the most immediate price risk given it absorbed a roughly 9% single-day selloff on Monday when the merger speculation first emerged, while BMY shareholders were widely viewed as the primary beneficiaries of any combination.
Investors are waiting for a potential Anthropic IPO in the coming months, but buying Micron and Nvidia could be a smarter bet.
Amazon and Alphabet are smart backdoor ways to gain exposure to Anthropic while owning two AI giants built to win (with or without the start-up).
Is Chipotle facing another food safety crisis?
The Ark Invest founder is betting big on SpaceX.
Suze Orman walked through a real SpaceX IPO trade that turned $10,000 into roughly $5,600 in seven weeks, and her lesson has nothing to do with rockets or Elon Musk.
Bristol Myers Squibb stock is surging Monday following a report of a potential mega-merger with a competitor.
Which of these three high-tech market newcomers is the best?
Is the hot IPO stock finally a bargain?
Video podcasting and gaming could be revenue generators for Netflix, but there isn't anything on the immediate horizon to help reverse stock price losses.
Chipotle Mexican Grill stock has jumped 17.1% over the past week, yet both its Discounted Cash Flow (DCF) intrinsic value estimate and market multiples currently point to an overvalued picture. For investors, that recent surge now sits against valuation checks that suggest the share price is running ahead of underlying fundamentals. The 17.1% gain over the last seven days puts fresh momentum behind Chipotle Mexican Grill, which now faces a higher bar for future returns to justify the...
The new CEO took over the conglomerate with a massive nest egg that he must try to deploy.
Chipotle shares shot up after strong Q2 earnings, but Starbucks stock could be the better buy.
(Bloomberg) -- Apnimed Inc., a late-stage drug developer focused on sleep apnea rose 6.3% on Friday after raising $192 million in an upsized US initial public offering.Most Read from BloombergSingapore's Gated Island for the Rich Is Marred by Decayed HomesAnthropic AI Models Hacked Three Organizations During TestsMicrosoft’s $450 Billion Jump Is Biggest in Stock Market HistoryChip Stocks Post Biggest Advance Since April 2025: Markets WrapUS Strikes Iran Again as Conflict Spreads Across Middle Ea
AbbVie lowered its full-year adjusted earnings outlook to account for its acquisition of Apogee Therapeutics, as the company logged higher profit and revenue in the recent quarter.
The IPO market has made an impressive comeback this year. Momentum began building in the first quarter and accelerated in the second, with traditional IPOs raising $114.1 billion through June 30, 2026 – roughly seven times the amount raised during the first half of 2025. SpaceX, the largest IPO in Wall Street history, understandably dominated the headlines and made Elon Musk the world’s first trillionaire, but the strength of the market extended well beyond a single blockbuster listing.Claim 55%
A China carveout could reduce regulatory complications related to SpaceX’s U.S. defense work and possible Beijing scrutiny.
A China carveout could reduce regulatory complications related to SpaceX’s U.S. defense work and possible Beijing scrutiny.
A China carveout could reduce regulatory complications related to SpaceX’s U.S. defense work and possible Beijing scrutiny.
Chipotle Mexican Grill raised its 2026 comparable sales growth outlook to low single-digit range.
Chipotle Mexican Grill managed to beat earnings and revenue estimates, but margins and labor pose a challenge for the burrito chain.
Yahoo Finance Senior Business Reporter Brooke DiPalma joins Josh Lipton on Asking for a Trend to break down Chipotle's (CMG) second quarter earnings results, including the company's latest performance, consumer trends, and what investors should watch next.
Short interest in the stock keeps climbing, but Musk says those betting against SpaceX have a ‘very low’ chance of surviving.
China's CXMT just pulled off the biggest semiconductor IPO in mainland history, and Micron shareholders felt the tremors almost immediately. Whether that reaction is panic or opportunity depends on one critical gap between the two chipmakers.
Memory and storage stocks came under pressure on July 27 after China’s leading semiconductor manufacturer, ChangXin Memory Technologies (CXMT), delivered a blockbuster Shanghai stock market debut to surpass a $500 billion valuation. Micron Technology, Inc. (NASDAQ:MU) shares fell 5%, Sandisk Corporation (NASDAQ:SNDK) declined around 12%, while Western Digital Corporation (NASDAQ:WDC) also traded sharply lower on […]
Circle announced it has acquired more than 680 blockchain patent families and nearly 1,000 issued patents from IBM's blockchain portfolio.
Sometimes three’s a crowd. But when it comes to the memory boom there’s room, and plenty of demand, for more chip makers.
Private-market platforms are giving accredited investors new ways to buy pre-IPO companies like SpaceX
Nio received about 18.24 million CXMT shares, though the stake is subject to an 18-month lockup.
We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.
